Table 1 Characteristics of the population
Before group (n = 147) | After group (n = 128) | p value | |
|---|---|---|---|
Sex (female) | 63 (43) | 48 (37) | 0.37 |
Age (years) | 58 [46–66] | 60 [52–68] | 0.14 |
Height (cm) | 170 [164–175] | 170 [165–175] | 0.33 |
Weight at ICU admission (kg) | 75 [63–83] | 73 [65–87] | 0.32 |
Weight at ICU discharge (kg) | 70.00 [59–80] | 70.00 [60–82] | 0.84 |
Weight loss at ICU discharge (kg) | 1.00 [0.00–3.00] | 0.00 [–0.50–2.00] | 0.53 |
BMI | 24 (21–28) | 24 (22–27) | 0.84 |
Nutritional status | |||
No or Mild malnutrition | 119 (81) | 95 (74) | 0.18 |
Severe malnutrition | 27 (19) | 33 (26) | 0.14 |
Oral alimentation at ICU discharge | 92 (63) | 75 (59) | 0.50 |
SAPSII score | 46 [36–59] | 48.50 [40–58] | 0.38 |
Severe patients (SAPSII > 56) | 41 (28) | 40 (31) | 0.54 |
Comorbidities | |||
Cardiovascular | 46 (31) | 47 (37) | 0.34 |
Respiratory | 37 (25) | 42 (33) | 0.73 |
Hepatic | 8 (5) | 5 (4) | 0.55 |
Renal | 11 (7) | 5 (4) | 0.21 |
Neurologic | 11 (7) | 8 (6) | 0.69 |
Diabetes | 16 (11) | 12 (9) | 0.70 |
Hematology disease | |||
AML | 56 (38) | 35 (27) | 0.06 |
ALL | 18 (12) | 4 (3) | 0.006 |
Lymphoma | 40 (27) | 50 (39) | 0.04 |
Myeloma | 17 (12) | 14 (11) | 0.87 |
Autologous SCT | 27 (18) | 30 (23) | 0.30 |
Allogeneic SCT | 32 (22) | 38 (30) | 0.13 |
Neutropenia | 43 (29) | 57 (45) | 0.009 |
CML, CLL | 16 (11) | 25 (20) | 0.04 |
Complete remission | 43 (34) | 31 (24) | 0.1 |
Main cause for ICU admission | |||
ARF | 50 (34) | 56 (44) | 0.1 |
Shock | 48 (33) | 35 (27) | 0.36 |
AKI | 18 (12) | 6 (5) | 0.03 |
Neurologic failure | 11 (7) | 15 (12) | 0.23 |
Others | 20 (14) | 16 (12) | 0.79 |
Organ support | |||
IMV | 72 (49) | 59 (46) | 0.72 |
Vasopressors | 83 (56) | 72 (56) | 1 |
RRT | 32 (22) | 35 (27) | 0.32 |
ICU length of stay (days) | 11 (13) | 14 (13) | 0.06 |
Hospital mortality | 72 (49) | 54 (42) | 0.28 |
Hospital length of stay (days) | 38 (41) | 37 (28) | 0.94 |